Variation in Prevalence and Burden of Chronic Obstructive Pulmonary Disease by State and Insurance Type in the United States
There is substantial state and payer variation in COPD prevalence and burden. Understanding this variation provides valuable insights into populations with unmet needs that can inform public health strategies to address gaps.
Authors
- Norbert Feigler
- Stephanie Leary
- Carol Bazell
- Hayley D. Germack
- Maggie Alston
- David M. Mannino (ORCID: https://orcid.org/0000-0003-3646-7828)
- Winston Fopalan
Institutions
- AstraZeneca (Switzerland) (CH)
- COPD Foundation (US)
- AstraZeneca (United States) (US)
- Milliman (United States) (US)
Publication Details
- Journal
- Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
- Published
- 2025-01-01
- DOI
- https://doi.org/10.15326/jcopdf.2024.0560
- Citations
- 2
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- AstraZeneca